Close

Piper Jaffray Upgrades Horizon Pharma (HZNP) to Overweight Amid Hyperion Deal

March 31, 2015 6:38 AM EDT Send to a Friend
Piper Jaffray upgraded Horizon Pharma (NASDAQ: HZNP) from Neutral to Overweight with a price target of $31.00 (from $21.00) following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login